Concepedia

Publication | Open Access

Efficacy and safety of QVA149 compared to the concurrent administration of its monocomponents indacaterol and glycopyrronium: the BEACON study

DOIFull Paper Access

73

Citations

23

References

2013

Year

Ronald Dahl, Dalal Jadayel, Vijay K. T. Alagappan, Hungta Chen, Banerji
International Journal of COPD

Abstract

The BEACON study demonstrated that once-daily QVA149 provides an efficacy and safety profile similar to the concurrent administration of its monocomponents indacaterol and glycopyrronium.

References

YearCitations

Page 1